HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q4 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $561,797 | +114.4% | 7,143 | +101.6% | 0.08% | +54.7% |
| Q3 2022 | $262,000 | -46.1% | 3,543 | -54.0% | 0.05% | -27.4% |
| Q1 2022 | $486,000 | -2.8% | 7,694 | +2.6% | 0.07% | -44.3% |
| Q2 2021 | $500,000 | -2.0% | 7,500 | +31.6% | 0.13% | +17.0% |
| Q2 2020 | $510,000 | +16.2% | 5,700 | +29.5% | 0.11% | +17.9% |
| Q1 2020 | $439,000 | -50.4% | 4,400 | -42.9% | 0.10% | -37.1% |
| Q4 2019 | $885,000 | +100.7% | 7,700 | +120.0% | 0.15% | +81.9% |
| Q3 2019 | $441,000 | -39.3% | 3,500 | -51.8% | 0.08% | -44.3% |
| Q4 2018 | $726,000 | +45.5% | 7,254 | +66.6% | 0.15% | +81.7% |
| Q3 2018 | $499,000 | -62.0% | 4,354 | -70.3% | 0.08% | -72.3% |
| Q2 2018 | $1,314,000 | +99.7% | 14,654 | +62.8% | 0.30% | +77.2% |
| Q1 2018 | $658,000 | -10.8% | 9,000 | -29.1% | 0.17% | +11.3% |
| Q4 2017 | $738,000 | +83.1% | 12,700 | +26.7% | 0.15% | +50.0% |
| Q4 2016 | $403,000 | – | 10,023 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |